Casinvent Pharma provides pharmaceutical solutions for the treatment of selected malignancies. It is based on the use of proprietary selective inhibitors of enzymes from the CK1 family for leukemia cell migration into lymphoid organs.
Something missing or incorrect on this page? Help us enrich this information
